Inhibition of Smad7 using antisense oligonucleotides decreased inflammation in an animal model of TNBS-induced colitis (Boirivant et al., 2006) and showed clinical remission in patients with CD (Monteleone et al., 2012). Here, SMAD7 is linked to Cowden disease.